piracetam has been researched along with Cardiovascular Diseases in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 7.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 3.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| " When prescribing these drugs to patients of this age bracket, treatment should be based not only on the diagnosis and seizure type but also on the propensity of the drugs for adverse effects and their drug-drug interactions." | 2.48 | Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. ( Dostic, M; Jankovic, SM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medvedev, VE | 1 |
| Frolova, VI | 1 |
| Epifanov, AV | 1 |
| Svalheim, S | 1 |
| Luef, G | 1 |
| Rauchenzauner, M | 1 |
| Mørkrid, L | 1 |
| Gjerstad, L | 1 |
| Taubøll, E | 1 |
| Jankovic, SM | 1 |
| Dostic, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levetiracetam, Carbamazepine and Lamotrigine and Hormonal Side Effects in Adult Males and Females.[NCT00460070] | 240 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for piracetam and Cardiovascular Diseases
| Article | Year |
|---|---|
Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.
Topics: Aged; Animals; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Choice Behavior; Drug Intera | 2012 |
1 trial available for piracetam and Cardiovascular Diseases
| Article | Year |
|---|---|
[New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
Topics: Cardiovascular Diseases; Depressive Disorder; Female; gamma-Aminobutyric Acid; Humans; Male; Middle | 2014 |
1 other study available for piracetam and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Comorbidity; Epilepsy; F | 2010 |